Burr Ridge, IL – According to filings with the U.S. Securities and Exchange Commission, SkinCure Oncology is raising $30,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Kerwin Brandt played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Skincure Oncology

SkinCure Oncology helps practices capitalize on new technology to treat the ever-increasing incidence of skin cancer, which is expanding with the aging U.S. population. The goal for SkinCure Oncology is to provide better access to this new non-surgical alternative for certain patients, including those with co-morbid conditions of blood thinner maintenance and diabetic concerns.

To learn more about Skincure Oncology, visit http://skincureoncology.com/

Contact:
Kerwin Brandt, Chief Executive Officer
630-601-4049
kbrandt@skincureoncology.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved